351 related articles for article (PubMed ID: 29527628)
1. Efficiencies of Low-Level Laser Therapy (LLLT) and Gabapentin in the Management of Peripheral Neuropathy: Diabetic Neuropathy.
Abdel-Wahhab KG; Daoud EM; El Gendy A; Mourad HH; Mannaa FA; Saber MM
Appl Biochem Biotechnol; 2018 Sep; 186(1):161-173. PubMed ID: 29527628
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of low-power laser therapy in improvement of the peripheral neuropathy induced by xenobiotics in rats.
Mannaa FAE; Abdel-Wahhab KGE; Daoud EM; El Gendy AAR; Saber MM; Fadl NN
Biochem Biophys Rep; 2021 Sep; 27():101085. PubMed ID: 34381880
[TBL] [Abstract][Full Text] [Related]
3. Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy.
Lindner MD; Bourin C; Chen P; McElroy JF; Leet JE; Hogan JB; Stock DA; Machet F
Exp Clin Psychopharmacol; 2006 Feb; 14(1):42-51. PubMed ID: 16503704
[TBL] [Abstract][Full Text] [Related]
4. Effect of levetiracetam versus gabapentin on peripheral neuropathy and sciatic degeneration in streptozotocin-diabetic mice: Influence on spinal microglia and astrocytes.
Reda HM; Zaitone SA; Moustafa YM
Eur J Pharmacol; 2016 Jan; 771():162-72. PubMed ID: 26712375
[TBL] [Abstract][Full Text] [Related]
5. Gabapentin therapy improves heart rate variability in diabetic patients with peripheral neuropathy.
Ermis N; Gullu H; Caliskan M; Unsal A; Kulaksizoglu M; Muderrisoglu H
J Diabetes Complications; 2010; 24(4):229-33. PubMed ID: 19195912
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats.
Attia HN; Al-Rasheed NM; Al-Rasheed NM; Maklad YA; Ahmed AA; Kenawy SA
Behav Pharmacol; 2012 Apr; 23(2):153-61. PubMed ID: 22411174
[TBL] [Abstract][Full Text] [Related]
7. Neuronal hyperactivity at the spinal cord and periaqueductal grey during painful diabetic neuropathy: effects of gabapentin.
Morgado C; Terra PP; Tavares I
Eur J Pain; 2010 Aug; 14(7):693-9. PubMed ID: 20056558
[TBL] [Abstract][Full Text] [Related]
8. Anti-allodynic and neuroprotective effects of koumine, a Benth alkaloid, in a rat model of diabetic neuropathy.
Ling Q; Liu M; Wu MX; Xu Y; Yang J; Huang HH; Yu CX
Biol Pharm Bull; 2014; 37(5):858-64. PubMed ID: 24790009
[TBL] [Abstract][Full Text] [Related]
9. A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin.
Ali G; Subhan F; Abbas M; Zeb J; Shahid M; Sewell RD
Naunyn Schmiedebergs Arch Pharmacol; 2015 Nov; 388(11):1129-40. PubMed ID: 26134846
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats.
Wodarski R; Clark AK; Grist J; Marchand F; Malcangio M
Eur J Pain; 2009 Sep; 13(8):807-11. PubMed ID: 18977160
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain.
Chen SR; Samoriski G; Pan HL
Neuropharmacology; 2009 Aug; 57(2):121-6. PubMed ID: 19422840
[TBL] [Abstract][Full Text] [Related]
12. The Therapeutic Effect of Dexmedetomidine on Rat Diabetic Neuropathy Pain and the Mechanism.
Lu Y; Lin B; Zhong J
Biol Pharm Bull; 2017 Sep; 40(9):1432-1438. PubMed ID: 28626198
[TBL] [Abstract][Full Text] [Related]
13. Peripheral neuropathy response to erythropoietin in type 2 diabetic patients with mild to moderate renal failure.
Hosseini-Zare MS; Dashti-Khavidaki S; Mahdavi-Mazdeh M; Ahmadi F; Akrami S
Clin Neurol Neurosurg; 2012 Jul; 114(6):663-7. PubMed ID: 22296650
[TBL] [Abstract][Full Text] [Related]
14. 6-Methoxyflavanone attenuates mechanical allodynia and vulvodynia in the streptozotocin-induced diabetic neuropathic pain.
Akbar S; Subhan F; Karim N; Shahid M; Ahmad N; Ali G; Mahmood W; Fawad K
Biomed Pharmacother; 2016 Dec; 84():962-971. PubMed ID: 27764759
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils Infiltrate the Spinal Cord Parenchyma of Rats with Experimental Diabetic Neuropathy.
Newton VL; Guck JD; Cotter MA; Cameron NE; Gardiner NJ
J Diabetes Res; 2017; 2017():4729284. PubMed ID: 28293643
[TBL] [Abstract][Full Text] [Related]
16. Effect of Low Level Laser Therapy on serum vitamin D and magnesium levels in patients with diabetic peripheral neuropathy - A pilot study.
Anju M; Chacko L; Chettupalli Y; Maiya AG; Saleena Ummer V
Diabetes Metab Syndr; 2019; 13(2):1087-1091. PubMed ID: 31336449
[TBL] [Abstract][Full Text] [Related]
17. Quercetin and low level laser therapy promote wound healing process in diabetic rats via structural reorganization and modulatory effects on inflammation and oxidative stress.
Ahmed OM; Mohamed T; Moustafa H; Hamdy H; Ahmed RR; Aboud E
Biomed Pharmacother; 2018 May; 101():58-73. PubMed ID: 29477473
[TBL] [Abstract][Full Text] [Related]
18. Diabetes-induced impairments of the exocytosis process and the effect of gabapentin: the link with cholesterol level in neuronal plasma membranes.
Trikash I; Gumenyuk V; Kuchmerovska T
Neurochem Res; 2015 Apr; 40(4):723-32. PubMed ID: 25614181
[TBL] [Abstract][Full Text] [Related]
19. Gabapentin relieves mechanical, warm and cold allodynia in a rat model of peripheral neuropathy.
Back SK; Won SY; Hong SK; Na HS
Neurosci Lett; 2004 Sep; 368(3):341-4. PubMed ID: 15364424
[TBL] [Abstract][Full Text] [Related]
20. A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure.
Pierce DA; Holt SR; Reeves-Daniel A
Clin Ther; 2008 Sep; 30(9):1681-4. PubMed ID: 18840374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
